RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 156 filers reported holding RELAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,341,445 | -33.0% | 1,943,097 | 0.0% | 0.54% | -22.8% |
| Q2 2023 | $24,405,298 | -23.7% | 1,943,097 | 0.0% | 0.71% | -25.3% |
| Q1 2023 | $32,002,807 | +10.2% | 1,943,097 | 0.0% | 0.94% | +16.0% |
| Q4 2022 | $29,029,869 | -33.2% | 1,943,097 | 0.0% | 0.82% | -35.4% |
| Q3 2022 | $43,467,000 | +33.6% | 1,943,097 | 0.0% | 1.26% | +23.7% |
| Q2 2022 | $32,546,000 | -44.0% | 1,943,097 | 0.0% | 1.02% | -12.5% |
| Q1 2022 | $58,156,000 | -51.3% | 1,943,097 | -50.0% | 1.16% | +26.6% |
| Q4 2021 | $119,344,000 | +94.8% | 3,886,194 | +100.0% | 0.92% | +3.4% |
| Q3 2021 | $61,266,000 | -58.5% | 1,943,097 | -51.9% | 0.89% | -7.2% |
| Q2 2021 | $147,684,000 | +111.7% | 4,036,194 | +100.0% | 0.96% | +8.7% |
| Q1 2021 | $69,766,000 | -27.9% | 2,018,097 | -13.4% | 0.88% | -15.1% |
| Q4 2020 | $96,810,000 | -2.4% | 2,329,407 | 0.0% | 1.04% | -28.2% |
| Q3 2020 | $99,209,000 | – | 2,329,407 | – | 1.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |